KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CareDx (CDNA) EBITDA Margin (2016 - 2026)

CareDx's EBITDA Margin history spans 14 years, with the latest figure at 1.02% for Q1 2026.

  • On a quarterly basis, EBITDA Margin rose 1681.0% to 1.02% in Q1 2026 year-over-year; TTM through Mar 2026 was 3.93%, a 1835.0% decrease, with the full-year FY2025 number at 8.1%, down 2032.0% from a year prior.
  • EBITDA Margin hit 1.02% in Q1 2026 for CareDx, up from 5.57% in the prior quarter.
  • Over the last five years, EBITDA Margin for CDNA hit a ceiling of 97.46% in Q4 2024 and a floor of 187.03% in Q4 2023.
  • Historically, EBITDA Margin has averaged 22.85% across 5 years, with a median of 21.85% in 2022.
  • Biggest five-year swings in EBITDA Margin: crashed -16382bps in 2023 and later surged 28449bps in 2024.
  • Tracing CDNA's EBITDA Margin over 5 years: stood at 23.21% in 2022, then crashed by -706bps to 187.03% in 2023, then surged by 152bps to 97.46% in 2024, then plummeted by -106bps to 5.57% in 2025, then skyrocketed by 118bps to 1.02% in 2026.
  • Business Quant data shows EBITDA Margin for CDNA at 1.02% in Q1 2026, 5.57% in Q4 2025, and 0.25% in Q3 2025.